Clinical Trial

A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the efficacy and safety of SHR-1314 injection in adult patients with active non-radiographic axial spondyloarthritis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-02; most recent amendment 2025-06-19.
Status change: Not Yet Recruiting → Recruiting 2025-05-07
Trial Details
NCT Number NCT06860750
Lead Sponsor Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Conditions Active Non-radiographic Axial Spondyloarthritis
Enrollment 380 participants
Start Date 2025-04-29
Primary Completion 2028-02 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-06-22